Price$33.60-9.27 (-21.62%)
2026-03-042026-06-05
News · 26 weeks135+100%
2025-12-142026-06-07
Mix4590d
- Other15(33%)
- Insider14(31%)
- SEC Filings7(16%)
- Offering5(11%)
- Earnings3(7%)
- Analyst1(2%)
Latest news
25 items- SECMedline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement8-K - Medline Inc. (0002046386) (Filer)
- INSIDERLarge owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERDirector Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- PRMedline's Prime Vendor model expands outside the United StatesAgreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement is with Mohawk Medbuy (MMC), one of Canada's largest healthcare procurement organizations, to support warehouse and supply chain logistics for its hospitals in Southwestern Ontario and builds from best practices from similar agreements with hundreds of healthcare providers in the U.S.
- PRMedline Inc. announces closing of upsized secondary offering of Class A common stockNORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei
- PRMedline announces participation in upcoming investor conferencesNORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET. Webcasts of the presentations will be a
- PRMediWound Reports First Quarter 2026 Financial Results and Provides Corporate UpdateEscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut
- INSIDERLarge owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- INSIDERLarge owner Bcp 8 Holdings Mozart Manager L.L.C. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECSEC Form 424B4 filed by Medline Inc.424B4 - Medline Inc. (0002046386) (Filer)
- INSIDERLarge owner Hellman & Friedman Capital Partners X (Parallel), L.P. disposed of 18,156,867 units of Class B Common Stock and converted options into 18,156,867 shares (SEC Form 4)4 - Medline Inc. (0002046386) (Issuer)
- SECSEC Form EFFECT filed by Medline Inc.EFFECT - Medline Inc. (0002046386) (Filer)
- PRMedline Inc. announces pricing of upsized secondary offering of Class A common stockNORTHFIELD, Ill., May 21, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today the pricing of its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. The offering is expected to close on May 28, 2026, subject to customary closing conditions. M
- SECSEC Form S-1MEF filed by Medline Inc.S-1MEF - Medline Inc. (0002046386) (Filer)
- PRMedline expands animal health portfolio with spay/neuter surgical packsReady-to-use packs help reduce prep time and improve inventory management, allowing organizations to focus more on patient careNORTHFIELD, Ill., May 20, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced the availability of custom spay/neuter surgical packs designed to help animal shelters and humane societies, high-volume spay and neuter clinics, and veterinary practices streamline procedures, reduce staff burden and help enhance access to spay and neuter programs. Millions of pets are spayed and neutered annually in the United States, and organized surgery packs can group es
- PRMedline Inc. announces launch of secondary offering of Class A common stockNORTHFIELD, Ill., May 20, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") have commenced an underwritten public offering of 60,000,000 shares of Medline's Class A common stock pursuant to a registration statement filed with the Securities and Exchange Commission (the "SEC"). Additionally, the Selling Stockholders intend to grant the underwriters a 30-day option to purchase up to an additional 9,000,000 shares of Medline's Class A common stock. Medline is not selling any sha
- SECSEC Form S-1 filed by Medline Inc.S-1 - Medline Inc. (0002046386) (Filer)
- PRMedline deploys new AutoStore installation at distribution center in Aurora, ColoradoNORTHFIELD Ill., May 18, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) has unveiled a new AutoStore™ installation at its distribution center in Aurora, Colo., as part of an ongoing effort to drive efficiency, optimize fulfillment and increase order capacity amid growing customer demand in the region. This is Medline's 24th AutoStore installation nationwide. AutoStore is an automated storage and retrieval system that uses robots and high-density storage technology to streamline fulfillment, increase throughput and drive distribution efficiency. Medline's AutoStore installation in Au
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.SCHEDULE 13G/A - Medline Inc. (0002046386) (Subject)
- SECSEC Form 10-Q filed by Medline Inc.10-Q - Medline Inc. (0002046386) (Filer)
- SECMedline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Medline Inc. (0002046386) (Filer)
MDLN FAQ
6 questionsWhere does MDLN stock trade?
Medline Inc. (MDLN) is listed on NASDAQ.What sector and industry is MDLN in?
Medline Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did Medline Inc. go public?
Medline Inc. (MDLN) completed its IPO in 2025.What are analysts saying about MDLN?
Medline Inc. has had 8 recent analyst actions on file. The most recent action was from Citigroup: Buy on 2026-03-11. Recent price targets range from $3800.00 to $4800.00.What companies are similar to MDLN?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), RMD (ResMed Inc.). Compare MDLN side-by-side with any of them on Quantisnow.How can I track MDLN on Quantisnow?
Quantisnow aggregates Medline Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow MDLN to receive live email and push alerts on every new disclosure.